United States

This biotech company uses AI, computation, and biological automation to speed up the development of small molecule and protein therapeutics. Their goal is to reduce the time and cost of drug development while increasing the success rate of bringing new medicines to patients. They have two drug discovery engines, ELVIS™ and ROSALYND™, which can design both small molecule and protein therapeutics. Their technology covers all stages of early drug discovery and is being applied to various areas such as neuroscience, infectious disease, immunology, and oncology.

Google

Gestor de producte

Científic de dades

1910 Genetics

1910 Genetics Ofertes obertes

Estàs preparat per fer un salt en la teva carrera? Dona un cop d'ull a aquests llocs oberts a 1910 Genetics.